| Hang Seng Index | 23.920 HKD | +0.280 | +1.184% | 286.71M | 6.84B | 23.658 (+1.109%) HKD as at 2025/06/19 | | |
| Hang Seng TECH Index | 5.030 HKD | +0.038 | +0.761% | 1.03B | 5.18B | 5.000 (+0.610%) HKD as at 2025/06/19 | | |
| Hang Seng China Enterprises | 88.220 HKD | +1.160 | +1.332% | 53.48M | 4.69B | 88.939 (-0.808%) HKD as at 2025/06/18 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 4.752 HKD | +0.044 | +0.935% | 150.23M | 715.02M | 4.717 (+0.751%) HKD as at 2025/06/19 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.854 HKD | -0.030 | -1.592% | 305.45M | 568.42M | 1.881 (-1.414%) HKD as at 2025/06/19 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.334 HKD | -0.054 | -2.261% | 107.28M | 251.83M | 2.381 (-1.990%) HKD as at 2025/06/19 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.035 HKD | +0.113 | +2.296% | 36.89M | 184.71M | 4.940 (+1.923%) HKD as at 2025/06/19 | | |
| Hang Seng TECH Index | 10.760 HKD | +0.040 | +0.373% | 12.03M | 129.53M | 10.976 (-1.967%) HKD as at 2025/06/18 | | |
| HSI ESG Enhanced Index (net total return index) | 49.060 HKD | +0.280 | +0.574% | 2.52M | 123.73M | 49.153 (-0.189%) HKD as at 2025/06/19 | | |
| CSI 300 | 43.500 HKD | +0.040 | +0.092% | 1.88M | 81.89M | 43.519 (-0.043%) HKD as at 2025/06/19 | | |
| Hang Seng TECH Index | 5.100 HKD | +0.025 | +0.493% | 13.88M | 70.78M | 5.200 (-1.925%) HKD as at 2025/06/18 | | |
| FTSE China A50 | 14.100 HKD | +0.090 | +0.642% | 3.48M | 48.98M | 14.097 (+0.021%) HKD as at 2025/06/18 | | |
| Hang Seng China Enterprises | 10.500 HKD | +0.070 | +0.671% | 4.66M | 48.86M | 10.523 (-0.222%) HKD as at 2025/06/18 | | |
| London Gold Fixing Price | 2,422.000 HKD | -2.000 | -0.083% | 17.70K | 42.88M | N/A | | |
| FTSE China A50 | 13.140 HKD | +0.060 | +0.459% | 1.92M | 25.23M | 13.057 (+0.633%) HKD as at 2025/06/19 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 4.390 HKD | -0.056 | -1.260% | 5.02M | 22.11M | 4.383 (+0.151%) HKD as at 2025/06/18 | | |
| Hang Seng High Dividend Yield | 27.440 HKD | +0.180 | +0.660% | 736.11K | 20.12M | 27.871 (-1.546%) HKD as at 2025/06/18 | | |
| MSCI Asia APEX 50 | 61.140 HKD | +0.680 | +1.125% | 285.26K | 17.40M | 61.401 (-0.425%) HKD as at 2025/06/18 | | |
| CSI 300 | 39.860 CNY | +0.080 | +0.201% | 355.80K | 14.19M | 39.885 (-0.062%) CNY as at 2025/06/19 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 17.220 HKD | -0.200 | -1.148% | 774.60K | 13.34M | 17.656 (-2.469%) HKD as at 2025/06/18 | | |
| MSCI China | 23.800 HKD | +0.200 | +0.847% | 479.63K | 11.40M | 24.158 (-1.483%) HKD as at 2025/06/18 | | |
| FTSE China A50 | 12.900 CNY | +0.060 | +0.467% | 670.00K | 8.63M | 12.916 (-0.122%) CNY as at 2025/06/18 | | |
| S&P GSCI Crude Oil Index Excess Return | 7.285 HKD | -0.015 | -0.205% | 1.11M | 8.06M | 7.256 (+0.400%) HKD as at 2025/06/18 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.126 HKD | +0.064 | +2.090% | 2.01M | 6.27M | 3.070 (+1.814%) HKD as at 2025/06/19 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 3.856 HKD | -0.038 | -0.976% | 1.41M | 5.46M | 3.888 (-0.826%) HKD as at 2025/06/19 | | |
| Hang Seng Index | 21.840 CNY | +0.180 | +0.831% | 242.00K | 5.29M | 21.681 (+0.736%) CNY as at 2025/06/19 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 12.950 HKD | -0.020 | -0.154% | 381.88K | 4.95M | 12.951 (-0.009%) HKD as at 2025/06/19 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Nikkei Stock Average Index | 60.580 HKD | +0.120 | +0.198% | 73.84K | 4.48M | 60.483 (+0.161%) HKD as at 2025/06/19 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 3.292 HKD | -0.060 | -1.790% | 1.22M | 4.06M | 3.452 (-4.641%) HKD as at 2025/06/18 | | |
| Hong Kong Interbank Offered Rate | 1,159.500 HKD | -0.150 | -0.013% | 3.47K | 4.02M | 1,159.077 (+0.037%) HKD as at 2025/06/19 | | |